Interferon-γ induces apoptosis and augments the expression of Fas and Fas ligand by microglia in vitro

Experimental Neurology

Volumn 162, Issue 2, 2000, Pages 290-296

  Badie, Behnam ^a   Schartner, Jill ^a   Vorpahl, Jessica ^a   Preston, Keith ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Apoptosis; Fas; Fas ligand; Interferon ; Microglia

Indexed keywords

CASPASE INHIBITOR; FAS ANTIGEN; FAS LIGAND; RECOMBINANT GAMMA INTERFERON;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENCEPHALITIS; FLOW CYTOMETRY; GENE OVEREXPRESSION; GLIOMA CELL; IMMUNOMODULATION; IMMUNOPATHOGENESIS; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034048666     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1999.7345     Document Type: Article

References (37)

1. Bellgrau D., Gold D., Selawry H., Moore J., Franzusoff A., Duke R. A role for CD95 ligand in preventing graft rejection. Nature. 377:1995;630-632.
2. Blasi E., Barluzzi R., Bocchini B., Mazzolla R., Bistoni F. Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. Journal of Neuroimmunology. 27:1990;229-237.
3. Bonetti B., Pohl J., Gao Y. L., Raine C. S. Cell death during autoimmune demyelination: Effector but not target cells are eliminated by apoptosis. J. Immunol. 159:1997;5733-5741.
4. Bonetti B., Raine C. S. Multiple sclerosis: Oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann. Neurol. 42:1997;74-84.
5. Brown S. B., Savill J. Phagocytosis triggers macrophage release of Fas ligand and induces apoptosis of bystander leukocytes. J. Immunol. 162:1999;480-485.
6. Cheng Y., Deshmukh M., D'Costa A., Demaro J. A., Gidday J. M., Shah A., Sun Y., Jacquin M. F., Johnson E. M., Holtzman D. M. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury [see comments]. J. Clin. Invest. 101:1998;1992-1994.
7. Choi C., Park J. Y., Lee J., Lim J. H., Shin E. C., Ahn Y. S., Kim C. H., Kim S. J., Kim J. D., Choi I. S., Choi I. H. Fas ligand and fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma. J. Immunol. 162:1999;1889-1895.
8. Corradin S. B., Mauel J., Donini S. D., Quattrocchi E., Ricciardi-Castagnoli P. Inducible nitric oxide synthase activity of cloned murine microglial cells. Glia. 7:1993;255-262.
9. Dowling P., Shang G., Raval S., Menonna J., Cook S., Husar W. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J. Exp. Med. 184:1996;1513-1518.
10. D'Souza S. D., Bonetti B., Balasingam V., Cashman N. R., Barker P. A., Troutt A. B., Raine C. S., Antel J. P. Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J. Exp. Med. 184:1996;2361-2370.
11. Ford A. L., Foulcher E., Lemckert F. A., Sedgwick J. D. Microglia induce CD4 T lymphocyte final effector function and death. J. Exp. Med. 184:1996;1737-1745.
12. Frei K., Siepl C., Groscurth P., Bodmer S., Schwerdel C., Fontana A. Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells. Eur. J. Immunol. 17:1987;1271-1278.
13. Gehrmann J., Matsumoto Y., Kreutzberg G. W. Microglia: Intrinsic immuneffector cell of the brain. Brain Res. Rev. 20:1995;269-287.
14. Gessani S., Belardelli F. IFN-gamma expression in macrophages and its possible biological significance. Cytokine Growth Factor Rev. 9:1998;117-123.
15. Griffith T., Brunner T., Fletcher S., Green D., Ferguson T. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 270:1995;1189-1192.
16. Keane M. M., Ettenberg S. A., Lowrey G. A., Russell E. K., Lipkowitz S. Fas expression and function in normal and malignant breast cell lines. Cancer Res. 56:1996;4791-4798.
17. Leithauser F., Dhein J., Mechtersheimer G., Koretz K., Bruderlein S., Henne C., Schmidt A., Debatin K. M., Krammer P. H., Moller P. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest. 69:1993;415-429.
18. Lowin B., Hahne M., Mattmann C., Tschopp J. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature. 370:1994;650-652.
19. Lynch D., Ramsdell F., Alderson M. Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today. 16:1995;569-574.
20. Matsuyama T., Hata R., Tagaya M., Yamamoto Y., Nakajima T., Furuyama J., Wanaka A., Sugita M. Fas antigen mRNA induction in postischemic murine brain. Brain Res. 657:1994;342-346.
21. Moore S., Thanos S. The concept of microglia in relation to central nervous system disease and regeneration. Progr. Neurobiol. 48:1996;441-460.
22. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
23. Nishimura T., Akiyama H., Yonehara S., Kondo H., Ikeda K., Kato M., Iseki E., Kosaka K. Fas antigen expression in brains of patients with Alzheimer-type dementia. Brain Res. 695:1995;137-145.
24. Novelli F., Bernabei P., Ozmen L., Rigamonti L., Allione A., Pestka S., Garotta G., Forni G. Switching on of the proliferation or apoptosis of activated human T lymphocytes by IFN-gamma is correlated with the differential expression of the alpha- and beta-chains of its receptor. J. Immunol. 157:1996;1935-1943.
25. Novelli F., D'Elios M. M., Bernabei P., Ozmen L., Rigamonti L., Almerigogna F., Forni G., Del Prete G. Expression and role in apoptosis of the alpha- and beta-chains of the IFN-gamma receptor on human Th1 and Th2 clones. J. Immunol. 159:1997;206-213.
26. Ossina N. K., Cannas A., Powers V. C., Fitzpatrick P. A., Knight J. D., Gilbert J. R., Shekhtman E. M., Tomei L. D., Umansky S. R., Kiefer M. C. Interferon-gamma modulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J. Biol. Chem. 272:1997;16351-16357.
27. Panek R. B., Benveniste E. N. Class II MHC gene expression in microglia: Regulation by the cytokines IFN-gamma, TNF-alpha, and TGF-beta. J. Immunol. 154:1995;2846-2854.
28. Saas P., Boucraut J., Quiquerez A. L., Schnuriger V., Perrin G., Desplat-Jego S., Bernard D., Walker P. R., Dietrich P. Y. CD95 (Fas/Apo-1) as a receptor governing astrocyte apoptotic or inflammatory responses: A key role in brain inflammation? J. Immunol. 162:1999;2326-2333.
29. Sethna M. P., Lampson L. A. Immune modulation within the brain: Recruitment of inflammatory cells and increased major histocompatibility antigen expression following intracerebral injection of interferon-gamma. J. Neuroimmunol. 34:1991;121-132.
30. Tamura T., Ueda S., Yoshida M., Matsuzaki M., Mohri H., Okubo T. Interferon-gamma induces Ice gene expression and enhances cellular susceptibility to apoptosis in the U937 leukemia cell line. Biochem. Biophys. Res. Commun. 229:1996;21-26.
31. Tanaka M., Itai T., Adachi M., Nagata S. Downregulation of Fas ligand by shedding. Nat. Med. 4:1998;31-36.
32. Vartanian T., Li Y., Zhao M., Stefansson K. Interferon-gamma-induced oligodendrocyte cell death: Implications for the pathogenesis of multiple sclerosis. Mol. Med. 1:1995;732-743.
33. Vogt M., Bauer M. K., Ferrari D., Schulze-Osthoff K. Oxidative stress and hypoxia/reoxygenation trigger CD95 (APO-1/Fas) ligand expression in microglial cells. FEBS Lett. 429:1998;67-72.
34. Waldner H., Sobel R. A., Howard E., Kuchroo V. K. Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. J. Immunol. 159:1997;3100-3103.
35. Wen L. P., Madani K., Fahrni J. A., Duncan S. R., Rosen G. D. Dexamethasone inhibits lung epithelial cell apoptosis induced by IFN- gamma and Fas. Am. J. Physiol. 273:1997;L921-L929.
36. Williams K., Ulvestad E., Antel J. P. B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ. Eur. J. Immunol. 24:1994;3031-3037.
37. Xu X., Fu X. Y., Plate J., Chong A. S. IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: Requirement of STAT1 protein for up-regulation of Fas and FasL expression. Cancer Res. 58:1998;2832-2837.